The effectiveness of shoulder injections.
- Registration Number
- NL-OMON22148
- Lead Sponsor
- Academisch ziekenhuis MaastrichtThe Research Institute Caphri of the University Maastricht
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 159
Eligible are patients of 18 years of age and older, who consult a physician for pain in the shoulder either at rest or elicited or provoked during movement of the shoulder. They must have a painful arc, with or without a disturbed scapulohumeral movement. The diagnosis is subacromial impingement syndrome.
Pain lasting less than 6 weeks;
prior injection with corticosteroids last 3 months, less than 100 degrees range of ante flexion;
more than 50% restriction of external glenohumeral rotation (compared to the non-affected side);
steroid or lidocaine allergy; pregnancy or supposed pregnancy; dementia;
(prior) purulent infection of the shoulder joints;
tumor, osteoporosis, rheumatoid arthritis (ACR criteria), referred pain from internal organs, or a cervical radicular syndrome as suspected or definite cause for SD;
stroke, polyneuropathy, multiple sclerosis, polymyalgia, ankylosing spondylitis (modified NY criteria) as suspected or definite cause for SD;
Whiplash, prior fractures or surgery of the shoulder, upper limb, neck or thorax;
currently receiving (or needing) treatment for serious behavioral, cognitive or psychiatric disorders.
Finally, patients who are not able to complete Dutch questionnaires independently and those who are reluctant to adhere to (allocated) treatments or to complete follow-up will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method At 3 - 6 - 12 - 26 weeks after the inclusion. <br />The primary clinical outcome measure will be patient perceived recovery measured with a Visual Analogue Scale (VAS) expressed as the proportion of patients indicating very large improvement (including full recovery). <br />The Visual Analogue Scale is a line of 10 cm in length, which is taken to represent the continuum of experienced pain. <br />It has been proved to be a simple, sensitive and reproducible instrument that enables the patient to express the pain in such a way that it can be given a numerical value. (Huskisson, 1983)
- Secondary Outcome Measures
Name Time Method